 |
| |
Source
|
Title
|
Issue Date
|
ICH |
Guideline for Good Clinical Practice
|
June1996 |
ICH |
Structure and Content of Clinical Study Reports
|
July 1996 |
ICH |
Guidance on Ethnic Factors in the Acceptability of Foreign Clinical Data |
June 1998 |
ICH |
Guidance on Statistical Principles for Clinical Trials |
Sept 1998 |
FDA |
General Considerations for the Clinical Evaluation of Drugs |
Feb 1997 |
FDA |
Conducting a Clinical Safety Review of a New Product Application and Prep a Report on the Review |
June 2005 |
FDA |
FDA Forms Distribution Page for CDER (including Assoc Forms) |
June 2005 |
FDA |
Binders (IND, NDA, ANDA, DMF) |
April 1998 |
21CFR314 |
Applications for FDA Approval to Market a New Drug |
April 2001 |
21CFR312 |
Investigational New Drug Application |
April 2004 |
21CFR56 |
Institutional Review Boards |
April 2004 |
21CFR50 |
Protection of Human Subjects |
April 2004 |
21CFR11 |
Electronic Records; Electronic Signatures |
April 2004 |
21CFR54 |
Financial Disclosure by Clinical Investigators |
April 2004 |
SFDA |
Regulations for Drug Registration |
2003 |
|
|